Research article · 29 Nov 2022
Conference abstractPublished 8 Sep 2014
USP monograph modernization-procedure review and development
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Public and regulatory expectation is that all pharmaceutical products, including over-the-counter (OTC) products and legacy prescription (Rx) products, will be safe and of high quality and those pharmacopeial requirements in USP-NF are adequate to ensure this level of quality. As USP global initiative to modernize existing monographs across all compendia, objectives and criteria for the monograph modernization are discussed. Identification, assay, organic impurities and other tests in the USP monograph are re-assessed and revised with modern analytical techniques. Orthogonal identification and organic impurities test with specified impurities based on HPLC/UHPLC are emphasized in the modernized monograph. Multi-sourced sample procurements and method development and validation by USP internal laboratories are utilized to fulfill the test procedures and additional specifications in the monograph, along with case studies for the critical steps/challenges of the procedure developments. With the modernized monographs and the support from FDA, the use of the test procedures in the monographs are important to strengthen the appropriate control of impurities in API, in excipients, and in drug products to improve the quality of the pharmaceutical products, to protect public health, and to achieve USP mission of providing highquality public standards.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 29 Nov 2022
Drug Development and Validation of Elemental Impurities Content in Methotrexate Injection USP 250 mg/10 ml by Inductively Coupled Plasma Mass Spectroscopy (ICP-MS)
Research article · 2020
DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS QUANTITATIVE DETERMINATION OF ELEMENTAL IMPURITIES AS PER ICH Q3D AND USP IN NON-AQUEOUS PARENTERAL FORMULATIONS WITH COMPLEX MATRIX CONTAINING CASTOR OIL BY ICP-MS.
Research article · 30 Dec 2014
DEVELOPMENT AND CHARACTERISATION OF ORAL SOFT GEL CONTAINING FLUCONAZOLE USP FOR THE TREATMENT OF ORAL CANDIDIASIS
Article · 2010
FORMULATION DEVELOPMENT AND EVALUATION OF NAPROXEN SODIUM TABLETS USP
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 13 Feb 2026
Regulatory Scenario of Pharmaceuticals during COVID-19 Pandemic in India
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Donald Min”

